EcoDrugPlus

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSPREG00000020304
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial

Ensembl ID : ENSPREG00000006801
Gene Symbol: LOC103466626
3 Cross references
207 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial-Like

Ensembl ID : ENSPREG00000005013
Gene Symbol: LOC103462181
3 Cross references
186 Possible Orthologues:

Jeltraxin-Like

Ensembl ID : ENSPREG00000019346
Gene Symbol: LOC103478631
2 Cross references
391 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSPREG00000013858
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSPREG00000019671
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSPREG00000011297
Gene Symbol: KIF11
3 Cross references
201 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSPREG00000012447
Gene Symbol: KIF5B
4 Cross references
234 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSPREG00000019436
Gene Symbol: KIF5B
4 Cross references
236 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSPREG00000018388
Gene Symbol: LTA4H
3 Cross references
203 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSPREG00000006924
Gene Symbol: LTB4R
3 Cross references
142 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSPREG00000006828
Gene Symbol: LOC103480275
3 Cross references
157 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).